Pharma Co. Snags $100M To Advance Psychedelic Treatment
By Gianna Ferrarin · January 5, 2024, 9:24 PM EST
The pharmaceutical arm of the nonprofit Multidisciplinary Association for Psychedelic Studies said on Friday it raised $100 million in an initial round of financing as it transitions to new leadership....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login